Ensign Peak Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-29,562	Closed	-$2.47M	–	1736
2024 Q4	$2.47M	Buy	29,562 +1,298	+5%	+$107K	﹤0.01%	849
2024 Q3	$2.07M	Sell	28,264 -13,373	-32%	-$1.01M	﹤0.01%	931
2024 Q2	$2.85M	Sell	41,637 -100,000	-71%	-$6.94M	0.01%	784
2024 Q1	$9.8M	Buy	141,637 +98,574	+229%	+$6.78M	0.02%	456
2023 Q4	$3.08M	Hold	43,063	–	–	0.01%	754
2023 Q3	$2.24M	Sell	43,063 -825	-2%	-$48.1K	﹤0.01%	800
2023 Q2	$2.78M	Hold	43,888	–	–	0.01%	762
2023 Q1	$2.38M	Buy	43,888 +16,948	+63%	+$819K	0.01%	781
2022 Q4	$1.43M	Buy	26,940 +2,600	+11%	+$130K	﹤0.01%	942
2022 Q3	$1.13M	Sell	24,340 -101,153	-81%	-$5.28M	﹤0.01%	1005
2022 Q2	$7.16M	Sell	125,493 -9,060	-7%	-$514K	0.02%	438
2022 Q1	$8.23M	Buy	134,553 +11,226	+9%	+$583K	0.02%	470
2021 Q4	$6.46M	Buy	123,327 +39,067	+46%	+$1.64M	0.01%	592
2021 Q3	$3.14M	Buy	84,260 +12,463	+17%	+$433K	0.01%	859
2021 Q2	$2.93M	Hold	71,797	–	–	0.01%	899
2021 Q1	$2.44M	Hold	71,797	–	–	0.01%	1010
2020 Q4	$2.28M	Buy	71,797 +43,806	+157%	+$1.15M	0.01%	985
2020 Q3	$718K	Buy	+27,991	New	+$639K	﹤0.01%	1435